CATHERINE BRICKLEY: Open Payments
NPI 1801869029 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 37 payments from 20 companies in 2025. Trend: 2023 $1,119 · 2024 $1,157 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $158 |
| ABBVIE INC. | 4 | $107 |
| Daiichi Sankyo Inc. | 4 | $84 |
| Eisai Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| PFIZER INC. | 2 | $38 |
| Pharmacosmos Therapeutics Inc. | 2 | $30 |
| TerSera Therapeutics LLC | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| PharmaEssentia USA Corporation | 1 | $25 |
Products named: Trodelvy, Enhertu, ELAHERE, Lenvima, IBRANCE, VENCLEXTA, JEMPERLI, MONOFERRIC.
Industry payments across SC — which companies pay providers there.
